Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Grapsa, Irini"'
Autor:
Dimopoulos, Meletios A., Roussou, Maria, Gavriatopoulou, Maria, Zagouri, Flora, Migkou, Magdalini, Matsouka, Charis, Barbarousi, Despina, Christoulas, Dimitrios, Primenou, Erasmia, Grapsa, Irini, Terpos, Evangelos, Kastritis, Efstathios
Publikováno v:
In Clinical Lymphoma & Myeloma August 2009 9(4):302-306
Autor:
Papaconstantinou, Ioannis, Yiallourou, Anneza I., Dafnios, Nicolaos, Grapsa, Irini, Polymeneas, George, Voros, Dionysios
A 67-year-old male patient with diabetes mellitus and nephritic syndrome under cortisone treatment was admitted to our hospital with fever and severe perianal pain. Upon physical examination, a perianal abscess was identified. Furthermore, the scrotu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4485::dec7ba759d998047eb66ad241362c101
https://gnosis.library.ucy.ac.cy/handle/7/42220
https://gnosis.library.ucy.ac.cy/handle/7/42220
Purpose: Renal impairment is a frequent complication of multiple myeloma (MM) and is associated with significant morbidity and increased early death rate. Bortezomib is active and well tolerated in patients with MM who present or develop renal impair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0af17af49871e2d7f1a0b60c5a1553f1
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2954241
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2954241
The purpose of this analysis was to assess the effect of novel agent-based regimens on the improvement of renal impairment (RI) in newly diagnosed patients with multiple myeloma. Ninety-six consecutive patients with RI received conventional chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::83d6e7634e13692c5a32b0892b9a66a0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2951953
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2951953
Renal failure is a common feature of multiple myeloma and a major management problem. However there is limited data regarding the reversibility of renal failure, the kinetics of serum creatinine and the safety of novel agents such as bortezomib when
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::17e7c4aca908c66011b41ef6da0788d6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3137864
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3137864
Autor:
Roussou, Maria, Kastritis, Efstathios, Christoulas, Dimitrios, Migkou, Magdalini, Gavriatopoulou, Maria, Grapsa, Irini, Psimenou, Erasmia, Gika, Dimitra, Terpos, Evangelos, Dimopoulos, Meletios A.
Publikováno v:
In Leukemia Research 2010 34(10):1395-1397